| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/29/2005 | US20050214841 Substrate for biochip |
| 09/29/2005 | US20050214840 Restriction enzyme mediated method of multiplex genotyping |
| 09/29/2005 | US20050214839 Nuclease inhibitors and methods for their use |
| 09/29/2005 | US20050214838 Methods for mapping and sequencing nucleic acids |
| 09/29/2005 | US20050214837 Antibody specific for mutant presenilin 1 and method of use thereof |
| 09/29/2005 | US20050214836 Using expression of ovarian endometriosis-associated gene, tissue factor pathway inhibitor as diagnostic indicator of urogenital disorders |
| 09/29/2005 | US20050214835 Diagnosis and treatment of myocardial failure |
| 09/29/2005 | US20050214834 Using microsatellite primers to generate chromosome specific DNA probe |
| 09/29/2005 | US20050214833 Improved conjugation; proteases |
| 09/29/2005 | US20050214832 Microarray comprising immobilized cell recogniton molecules for use as diagnostic tool in detection of cancer cells |
| 09/29/2005 | US20050214831 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 09/29/2005 | US20050214830 Recombinant g protein coupled receptor for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 09/29/2005 | US20050214828 Using ultrviolet laser excitation and fluorescence to identify regions of hybridization along microarray comprised of immobilized polynucleotides; gene expression analysis; genomics |
| 09/29/2005 | US20050214827 Multicompartment microarray apparatus comprising signal element tethers and laser readable disk for use as tool in detection of preferential nucleotide sequences |
| 09/29/2005 | US20050214826 Using tumor protein gene expression to diagnose epithelial ovarian cancer |
| 09/29/2005 | US20050214825 Multiplex sample analysis on universal arrays |
| 09/29/2005 | US20050214824 Nucleic acid probe array comprising sets of probes for interrogating joining sequences between transcriptional units |
| 09/29/2005 | US20050214823 Nucleic acid microarray for identifying variation in preferential gene sequences |
| 09/29/2005 | US20050214822 Using cypin in assays, diagnostics and treatment of cognitive disorders |
| 09/29/2005 | US20050214821 Using vector transformation to transfer preferential sequences into host cell to treat pigmentation disorders including premature hair greying |
| 09/29/2005 | US20050214820 Diagnosis of sepsis using mitochondrial nucleic acid assays |
| 09/29/2005 | US20050214819 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/29/2005 | US20050214818 Using cells expressing armitage (ARMI) polypetide as models for id entifying modulators of cell proliferative disorders |
| 09/29/2005 | US20050214815 Biochip comprising ionic polymer coatings binding to a charge opposite substrate coatings through a binder; protein separation by ion exchange chromatographic method; analysis kits |
| 09/29/2005 | US20050214814 Identification of fat and lean phenotypes in chickens using molecular markers |
| 09/29/2005 | US20050214812 Assay for detecting methylation status by methylation specific primer extension (MSPE) |
| 09/29/2005 | US20050214811 Using restriction fragment length polymorphisms as tool in diagnosing dyslipidemia, cell proliferative and/or adrenal disorders; bioinformatics |
| 09/29/2005 | US20050214809 Real-time detection of nucleic acids and proteins |
| 09/29/2005 | US20050214808 Plant having tolerance to environmental stress |
| 09/29/2005 | US20050214807 Environmental sensitive fluorogenic compounds and their application for singlet oxygen and protein detection |
| 09/29/2005 | US20050214806 Microelectronic components and electronic networks comprising DNA |
| 09/29/2005 | US20050214805 Immunoglobulin replicase fusion for use in diagnosing nervous system and prion disorders |
| 09/29/2005 | US20050214803 High-density amine-functionalized surface |
| 09/29/2005 | US20050214802 screening inhibitors of caspase interaction with a melanoma-inhibitor of apoptosis (ML-IAP) chimera; diagnosing cancer |
| 09/29/2005 | US20050214797 Minor groove binders; quenchers |
| 09/29/2005 | US20050214796 Using cyclic amplification to generate probes for detection of preferential biopolymers; gene expression analysis |
| 09/29/2005 | US20050214795 Polypeptide for use as diagnostic indicator of cell proliferative disorders; immunotherapeutics; antitumor agents |
| 09/29/2005 | US20050214794 Alstroem syndrome gene, gene variants, expressed protein and methods of diagnosis for alstroem syndrome |
| 09/29/2005 | US20050214792 Compositions and methods relating to nucleic acid reference standards |
| 09/29/2005 | US20050214790 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatment of schizophrenia |
| 09/29/2005 | US20050214789 Sensors for biomolecular detection and cell classification |
| 09/29/2005 | US20050214788 Method and system for clustering and rescaling for molecular analysis |
| 09/29/2005 | US20050214787 Also probe consisting of the nucleic acid molecule, a reporter molecule (particularly a fluorophore), and a quencher molecule; used especially in hybridization assays and TaqMan (reg) based assays |
| 09/29/2005 | US20050214786 26 human secreted proteins |
| 09/29/2005 | US20050214784 Processes for detecting or quantifying nucleic acids using an array of fixed or immobilized nucleic acids |
| 09/29/2005 | US20050214782 High throughput screening; ELISA; PCR; blot analysis |
| 09/29/2005 | US20050214781 Ovarian specific nucleic acid (OSNA) for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy; genetic vaccines |
| 09/29/2005 | US20050214780 Using polymorphism in potassium channel interacting protein (KChIP1) as diagnostic indicator for pancreatic disorders |
| 09/29/2005 | US20050214779 Preparing microarray comprising two different nucleic acid ligands via fluid deposition and immobilization to solid support; gene expression analysis |
| 09/29/2005 | US20050214778 Preparing microarray comprising two different nucleic acid ligands via fluid deposition and immobilization to solid support; gene expression analysis |
| 09/29/2005 | US20050214777 Methods for in situ generation of nucleic acid arrays |
| 09/29/2005 | US20050214776 Photoprotein capable of binding coelenterazine and molecular oxygen, allows for emission of light at longer wavelengths as result of energy transfer; assay for screening HIV-1 protease inhibitors; microanalysis and drug discovery; kits |
| 09/29/2005 | US20050214775 Using computer controlled printhead dispension assembly to deposit fluid comprising biopolymer constituents onto solid support; microarrays; gene expression and/or protein analysis; proteomics; gene mapping |
| 09/29/2005 | US20050214774 Isolated monkey cathepsin S proteins, nucleic acid molecules encoding monkey cathepsin S proteins, and uses thereof |
| 09/29/2005 | US20050214772 Thio modified aptamer synthetic methods and compositions |
| 09/29/2005 | US20050214771 Methods for identifying risk of breast cancer and treatments thereof |
| 09/29/2005 | US20050214770 using primers generated to the internal transcribed spacer sequence of 16S-23S rDNA that specifically amplify mycobacteria other than tuberculosis (MOTT); kits |
| 09/29/2005 | US20050214769 Method for producing probe carrier, apparatus for producing the same and method for quality assurance therefor |
| 09/29/2005 | US20050214768 Regulation of human serine/threonine kinase |
| 09/29/2005 | US20050214764 Method for identifying, quantifying and/or characterizing an analyte |
| 09/29/2005 | US20050214763 Diagnostic and therapeutic use of an activator protein for vesicle secretion for neurodegenerative diseases |
| 09/29/2005 | US20050214760 Using tumor marker as diagnostic/prognostic tools in detection of cell proliferative disorders of urogenital system |
| 09/29/2005 | US20050214759 Enzymatic redox labelling of nucleic acids |
| 09/29/2005 | US20050214757 Diagnosis and therapy of conditions by detection or modulation of the alms1 gene or protein |
| 09/29/2005 | US20050214756 Cell visual characteristic-modifying sequences |
| 09/29/2005 | US20050214754 Process for identifying a novel target for use for the development of therapeutic modalities and drugs effective against tuberculosis |
| 09/29/2005 | US20050214753 Detection of nucleic acid hybrids |
| 09/29/2005 | US20050214752 Compositions and methods for determining epistatic relationships between HIV mutations that affect replication capacity |
| 09/29/2005 | US20050214751 Using virus infected cells as tools in identifying modulators of homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 (HERPUD1)/nef protein complexing; vircides |
| 09/29/2005 | US20050214750 Compositions and methods for determining the replication capacity of a pathogenic virus |
| 09/29/2005 | US20050214749 Using genomic variation/polymorphism to identify and predict effective viricidal agents |
| 09/29/2005 | US20050214748 Using severe acute respiratory syndrome (SARS) coronaviral nucleocapsid protein antigens as diagnostic indicators of respiratory disorders in humans; immunoassay |
| 09/29/2005 | US20050214747 Compositions and methods for analysis of target analytes |
| 09/29/2005 | US20050214746 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 09/29/2005 | US20050214745 Having a plate with a first surface containing a substance for capturing viable matter carried in a gas drawn through the inlet that is configured to maintain the viable matter in a living state without promoting growth of the viable matter. |
| 09/29/2005 | US20050214744 Computer database for determining/identifying polymorphic variations in viral polymerase which confers viricidal resistance |
| 09/29/2005 | US20050214743 Using reduced binding of viral particle specific antibodies as indicator of individuals with enhanced response to viral infection; viricides |
| 09/29/2005 | US20050214741 Method for formulating and immobilizing a matrix protein and a matrix protein for use in a sensor |
| 09/29/2005 | US20050214740 Device for measuring extracellular potential and manufacturing method of the same |
| 09/29/2005 | US20050214739 Expression of G protein coupled receptors in yeast |
| 09/29/2005 | US20050214738 Animal models comprising rapamycin binding (FRB) domain and target of rapamycin (TOR) sequence for use in identifying modulators of cellular pathways |
| 09/29/2005 | US20050214735 Method of visualizing proteins bound to protein-binding membranes |
| 09/29/2005 | US20050214734 Cell population provided with identification codes and method of screening cell population |
| 09/29/2005 | US20050214661 Structure formed with template having nanoscale features |
| 09/29/2005 | US20050214471 Molecular templating of a surface |
| 09/29/2005 | US20050214324 Culturing avian cells permissive for productive replication of the virus in a serum free medium containing a growth factor or an attachment factor, infecting of the cells with the virus, and cultivating in serum free media until progeny virus is produced |
| 09/29/2005 | US20050214318 Immunogenic composition and method of developing a vaccine based on fusion protein |
| 09/29/2005 | US20050214317 A binding site of the cystosolic protein cyclophilin A on human immunodeficiency virus capsid protein, which may be expressed by a recombinant viral, bacterial or yeast carrier; may be treated with neuraminidase or trypsin to remove sialic acid; immune stimulant such as teichoic acid or zymosan |
| 09/29/2005 | US20050214316 Generating and sequencing an infectious bursal disease virus cDNA from sample suspected of having a strain of IBDV, aligning the sequence with one or more IBDV sequences, and comparing relatedness of aligned IBDV sequences; selecting a vaccine for chickens, ducks, geese, pheasants, quail and turkeys. |
| 09/29/2005 | US20050214314 Human cytokine receptor |
| 09/29/2005 | US20050214305 VEGI, an inhibitor of angiogenesis and tumor growth |
| 09/29/2005 | US20050214292 Monitoring and inhibiting midkine gene expression activity; lupus nephritis; kits |
| 09/29/2005 | US20050214282 Expressed genes that define the osteoclast phenotype |
| 09/29/2005 | US20050214281 G-protein coupled receptor |
| 09/29/2005 | US20050214276 Delta 4, 5 glycuronidase and uses thereof |
| 09/29/2005 | US20050214275 Noninvasive fat modulation; utilizing active agents having reactive selectivity to metabolic regulatory system of cells; drug screening; animal models |
| 09/29/2005 | US20050214269 Induction of beta cell differentiation in human cells |
| 09/29/2005 | US20050214262 Population of hematopoietic cells, made to exhibit a greater clonogenic potential, engraftment potential, immune system reconstitution potential and/or proportion of CD34+ positive cells by culturing with a transition metal compound that chelates copper such as tetraethylenepentamine |
| 09/29/2005 | US20050214217 Methods of and pharmaceutical compositions for modulating T-lymphocyte adhesion, migration, gene expression and function by Glutamate and analogs thereof |
| 09/29/2005 | US20050212095 Substrate and method for measuring the electrophysiological properties of cell membranes |